MBL77 NO FURTHER A MYSTERY

mutations supplied The point that, as described down below, CLL therapy is based over the existence or absence of those mutations. The current consensus is usually that, apart from clonal mutations, subclonal mutations which has a variant allelic frequency starting from five to ten% (and so below the brink of detection by typical molecular tactics)